Sunday 27 January 2013

Washington dental board urged to investigate state's death cases


Washington dental board urged to investigate state's death cases
By DrBicuspid Staff
July 18, 2008 -- A top health official in Washington has urged the state's dental board to investigate all patient deaths related to dentistry, according to a seattlepi.com story.
In a recent letter to the Washington State Dental Quality Assurance Commission, Secretary of the Washington State Department of Health Mary Selecky mentioned a recent news story that revealed that the board might have been too soft in some cases.
"In an interview Wednesday, Selecky said the dental board assured her it will re-examine its death investigation process at its next meeting later this month," reportedseattlepi.com.

MedX signs U.S. distributor for Oralase


MedX signs U.S. distributor for Oralase
By DrBicuspid Staff
July 17, 2008 -- MedX Health of Mississauga, Ontario, has signed an exclusive distribution agreement with Technology4Medicine, a newly formed laser company in San Clemente, CA. Technology4Medicine will sell MedX Health's newest laser product, Oralase, in the U.S. once the product receives FDA marketing clearance.
Oralase is a low-level laser therapy (LLLT) device designed to alleviate pain and accelerate tissue repair following dental procedures. MedX has already applied for FDA clearance for Oralase.
"MedX is already well-established in the rehabilitation market, offering innovative laser and light therapy products that have successfully treated pain, sports injuries, and other conditions," said Steve Guillen, president and CEO of MedX Health in a press release. "We believe our products can offer patients with acute and chronic wounds a noninvasive, drug-free solution, and we fully intend to pursue these indications aggressively."

Articaine superior to lidocaine for anesthesia, survey finds


Articaine superior to lidocaine for anesthesia, survey finds
By Rosemary Frei, MSc, DrBicuspid.com contributing writer
July 17, 2008 -- Articaine had more than nine times the anesthetic success than lidocaine for dental anesthesia in a 10-study meta-analysis presented by University of Iowa researchers at the recent International Association for Dental Research (IADR) meeting in Toronto. However, significant differences between the studies cast doubt on the meaning of this result, according to another expert who attended the presentation.
Headed by Kellie Paxton, D.M.D., M.S., the research team searched PubMed (using Medical Subject Headings database search terms) for studies examining the anesthetic efficacy of initial administration of articaine/carticaine and lidocaine in dental applications. The team identified 77 studies but discarded 67 because they had "significant shortcomings," such as not being randomized or not having clearly reported outcomes.
The remaining 10 studies were performed in five different countries and were published between 1991 and 2007. They each used either articaine or lidocaine in a 4% solution 1:100,000 with epinephrine.
The team first summarized the key points in each of the studies with five-page abstraction forms, and an independent evaluator arbitrated disagreements about how to abstract the information. The primary focus was on the proportion of anesthesia administrations achieving pulpal anesthetic success, as measured by an electric pulp test and/or a visual analog scale for intraoperative pain. Secondary analyses were intended to evaluate the length of pulpal anesthesia.
However, a generalized lack of standardization and data made it impossible for the team to perform the secondary analyses, Dr. Paxton said. Two types of randomization were used in the 10 studies: a crossover design in which subjects used one type of treatment followed by the other, and independent sampling in which they were assigned to only one treatment.
"Because two forms of randomization were used in the studies we were analyzing, much heterogeneity was introduced into the meta-analysis," Dr. Paxton noted. "This is because estimation of the treatment effect is dictated by the study's design type."
Individually, two of the 10 studies reported a significantly superior performance of articaine hydrochloride compared to lidocaine hydrochloride, and a third study showed a trend toward such superiority. In four other studies, the observed rate of anesthetic success was greater for articaine but was not statistically significant. The three remaining studies each showed the two agents had similar anesthetic success.
The team then combined the data from the 10 studies and examined them with Fisher's method of combination of probabilities. They found articaine produced statistically significantly more anesthetic success than lidocaine. They also examined the combined data with a random effects model and found that articaine is associated with 9.21 times more anesthetic success than lidocaine (95% confidence interval 2.56-15.85).
However, when the team examined the differences between each of the 10 studies with respect to how the studies were conducted and how the results were reported, they found significant heterogeneity.
The chair of the IADR session, Zakaria Messieha, D.D.S., affirmed these results. "There is too much heterogeneity between the articaine and lidocaine studies to make this meta-analysis conclusive," said Dr. Messieha, an associate professor of clinical anesthesia at the University of Illinois at Chicago and a dental anesthesiologist in private practice in Glen Ellyn, IL.